FDA Accepts Supplement for Furosemide by Epic Pharma
The FDA has accepted a supplemental application for Furosemide submitted by Epic Pharma.
Asset / Drug
Drug and asset intelligence for Furosemide with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.